Stockholders’ Equity (Tables)
|
9 Months Ended |
Sep. 30, 2024 |
|---|
| Stockholders’ Equity [Abstract] |
|
| Schedule of Assumptions Used in the Black-Scholes Model |
The assumptions used in the
Black-Scholes Model are set forth in the table below.
| |
|
Nine
Months Ended
September 30, 2024 |
|
| |
|
Ondas
Holdings |
|
| Stock
price |
|
|
$0.72-1.40 |
|
| Risk-free
interest rate |
|
|
3.71-4.62% |
|
| Volatility |
|
|
56.15-82.03% |
|
| Expected
life in years |
|
|
2.00-5.00 |
|
| Dividend
yield |
|
|
0.00% |
|
|
| Schedule of Warrants Activity |
A summary of our Warrants
activity for the three and nine months ended September 30, 2024 and related information follows: | |
| Number of
Shares
Under
Warrant |
|
| Weighted
Average
Exercise
Price |
|
| Weighted
Average
Remaining
Contractual
Life |
|
| Balance as of January 1, 2024 |
| |
12,566,092 |
|
| $ |
2.22 |
|
| |
4.71 |
|
| Granted |
| |
14,435,301 |
|
| |
0.90 |
|
| |
|
|
| Exercised |
| |
(46,893 |
) |
| |
0.03 |
|
| |
|
|
| Cancelled |
| |
(464,290 |
) |
| |
9.32 |
|
| |
|
|
| Balance as of September 30, 2024 |
| |
26,490,210 |
|
| $ |
1.38 |
|
| |
4.09 |
|
|
| Schedule of Option Activity |
A summary of our Option activity
for the nine months ended September 30, 2024 and related information follows: | |
| Number of
Shares
Under
Option |
|
| Weighted
Average
Exercise
Price |
|
| Weighted
Average
Remaining
Contractual
Life |
|
| Balance as of January 1, 2024 |
| |
4,854,507 |
|
| $ |
4.59 |
|
| |
7.34 |
|
| Granted |
| |
804,500 |
|
| |
1.07 |
|
| |
|
|
| Exercised |
| |
(14,195 |
) |
| |
0.75 |
|
| |
|
|
| Forfeited |
| |
(258,109 |
) |
| |
1.75 |
|
| |
|
|
| Canceled |
| |
(698,838 |
) |
| |
6.86 |
|
| |
|
|
| Balance as of September 30, 2024 |
| |
4,687,865 |
|
| $ |
3.82 |
|
| |
7.63 |
|
| Vested and Exercisable as of September 30, 2024 |
| |
2,533,038 |
|
| $ |
5.19 |
|
| |
6.69 |
|
|
| Schedule of Stock-Based Compensation Expense for Stock Options |
Total stock-based compensation
expense for stock options for the three and nine months ended September 30, 2024 and 2023 is as follows:
| |
|
Three Months Ended
September
30, |
|
|
Nine Months Ended
September 30, |
|
| |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
| General and administrative |
|
$ |
67,656 |
|
|
$ |
1,843 |
|
|
$ |
207,016 |
|
|
$ |
209,313 |
|
| Sales and marketing |
|
|
40,021 |
|
|
|
126,868 |
|
|
|
191,987 |
|
|
|
385,455 |
|
| Research and development |
|
|
30,219 |
|
|
|
103,962 |
|
|
|
109,717 |
|
|
|
235,564 |
|
| Cost of goods sold |
|
|
18,293 |
|
|
|
16,144 |
|
|
|
55,341 |
|
|
|
35,166 |
|
| Total stock-based expense related to options |
|
$ |
156,189 |
|
|
$ |
248,817 |
|
|
$ |
564,061 |
|
|
$ |
865,498 |
|
Total stock-based compensation expense for restricted stock units for the three and nine months ended September
30, 2024 and 2023 is as follows:
| |
|
Three Months Ended
September
30, |
|
|
Nine Months Ended
September 30, |
|
| |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
| General and administrative |
|
$ |
49,010 |
|
|
$ |
(1,751,531 |
) |
|
$ |
155,644 |
|
|
$ |
(278,224 |
) |
| Sales and marketing |
|
|
- |
|
|
|
62,403 |
|
|
|
13,564 |
|
|
|
81,296 |
|
| Research and development |
|
|
- |
|
|
|
(826,564 |
) |
|
|
715 |
|
|
|
(32,220 |
) |
| Total stock-based expense related to restricted stock units |
|
$ |
49,010 |
|
|
$ |
(2,515,692 |
) |
|
$ |
169,923 |
|
|
$ |
(229,148 |
) |
|
| Schedule of Restricted Stock Unit Activity |
The following is a summary
of restricted stock unit activity for the three and nine months ended September 30, 2024: | |
| RSUs |
|
| Weighted
Average
Grant
Date Fair
Value |
|
| Weighted
Average
Vesting
Period
(Years) |
|
| Unvested balance as of January 1, 2024 |
| |
554,466 |
|
| $ |
1.14 |
|
| |
0.66 |
|
| Vested |
| |
(436,047 |
) |
| |
1.35 |
|
| |
|
|
| Unvested balance as of September 30, 2024 |
| |
118,419 |
|
| $ |
0.38 |
|
| |
0.00 |
|
|